Cita APA (7a ed.)
Mulas, O., Caocci, G., Annunziata, M., Martino, B., Luciano, L., Castagnetti, F., . . . De Gregorio, F. (2020). Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib. Hematological Oncology, 38(4), 607-611.
Cita Chicago Style (17a ed.)
Mulas, Olga, et al. "Favorable Outcome of Chronic Myeloid Leukemia Co‐expressing E13a2 and E14a2 Transcripts, Treated with Nilotinib." Hematological Oncology 38, no. 4 (2020): 607-611.
Cita MLA (9a ed.)
Mulas, Olga, et al. "Favorable Outcome of Chronic Myeloid Leukemia Co‐expressing E13a2 and E14a2 Transcripts, Treated with Nilotinib." Hematological Oncology, vol. 38, no. 4, 2020, pp. 607-611.
Precaución: Estas citas no son 100% exactas.